With effect from November 19, 2014, the subscription rights in Oasmia Pharmaceutical AB will be quoted on the list for Equity rights. Quotation will continue up until and including December 3, 2014.
| Instrument: | Subscription rights |
| Short name: | OASM TR |
| Round lot: | 1 |
| Clearing | Bilateral settlement at Euroclear Sweden |
| ISIN code: | SE0006452850 |
| Order book ID: | 104000 |
| Market Segment / no: | OMX STO Eq.rights,Subs.Opt, Int. shares/1 |
| Tick Size / no: | Other Equities / 227 |
| MIC Code: | XSTO |
With effect from November 19, 2014, the paid subscription shares will be quoted on the list for Equity rights. Quotation will continue up until and including December 15, 2014.
| Instrument: | Paid subscription shares |
| Short name: | OASM BTA |
| Round lot: | 1 |
| Clearing | Bilateral settlement at Euroclear Sweden |
| ISIN code: | SE0006452868 |
| Order book ID: | 104001 |
| Market Segment / no: | OMX STO Eq.rights,Subs.Opt, Int. shares/1 |
| Tick Size / no: | Other Equities / 227 |
| MIC Code: | XSTO |
For further information concerning this exchange notice please contact Niklas Ramstedt or Andreas Jensen, telephone +46 8 405 60 00, or iss@nasdaq.com.